Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
Bob Speil and Nate Williams open with the starfish principle—one doctor who doesn’t sell is worth the whole podcast—then analogize DSO dealmaking to Big Tobacco: a fortune in getting people hooked, almost nothing in talking them out of it. They take a highlighter to Chip Fichtner’s LPS 2025 scorecard and “just reconnect” emails, knocking the 6.75–11x EBITDA headlines down to work-backs, minority equity, and a commission machine now waving BlackRock, yachts, recruiting teams, and AI as reasons to hand over the name on the door. The closer is the real question under the sales copy: when private equity and family offices own the cash flow, who still owns the patient’s care—and why the honest answer still starts with just saying no.
